KR101414741B1 - The manufacturing method of green tea nut extract and compositions for anti-obesity containing green tea nut extract - Google Patents
The manufacturing method of green tea nut extract and compositions for anti-obesity containing green tea nut extract Download PDFInfo
- Publication number
- KR101414741B1 KR101414741B1 KR1020120069413A KR20120069413A KR101414741B1 KR 101414741 B1 KR101414741 B1 KR 101414741B1 KR 1020120069413 A KR1020120069413 A KR 1020120069413A KR 20120069413 A KR20120069413 A KR 20120069413A KR 101414741 B1 KR101414741 B1 KR 101414741B1
- Authority
- KR
- South Korea
- Prior art keywords
- green tea
- extract
- supercritical
- extraction
- defatted
- Prior art date
Links
- 244000269722 Thea sinensis Species 0.000 title claims abstract description 108
- 235000009569 green tea Nutrition 0.000 title claims abstract description 101
- 239000000284 extract Substances 0.000 title claims abstract description 98
- 230000003579 anti-obesity Effects 0.000 title claims abstract description 42
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 238000004519 manufacturing process Methods 0.000 title abstract description 9
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 43
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 40
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 38
- 229940094952 green tea extract Drugs 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 12
- 239000004480 active ingredient Substances 0.000 claims abstract description 10
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 80
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 20
- 239000000843 powder Substances 0.000 claims description 11
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 10
- 239000001569 carbon dioxide Substances 0.000 claims description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 9
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 38
- 210000000577 adipose tissue Anatomy 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 238000009825 accumulation Methods 0.000 abstract 1
- 238000000605 extraction Methods 0.000 description 45
- 230000000052 comparative effect Effects 0.000 description 26
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 24
- 238000005238 degreasing Methods 0.000 description 18
- 239000012530 fluid Substances 0.000 description 12
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 12
- 229930182490 saponin Natural products 0.000 description 12
- 150000007949 saponins Chemical class 0.000 description 12
- 102000015303 Fatty Acid Synthases Human genes 0.000 description 11
- 108010039731 Fatty Acid Synthases Proteins 0.000 description 11
- 230000003247 decreasing effect Effects 0.000 description 11
- 239000002245 particle Substances 0.000 description 10
- 239000003921 oil Substances 0.000 description 9
- 108010013563 Lipoprotein Lipase Proteins 0.000 description 8
- 102000043296 Lipoprotein lipases Human genes 0.000 description 8
- 102100031248 Patatin-like phospholipase domain-containing protein 2 Human genes 0.000 description 8
- 108050009145 Patatin-like phospholipase domain-containing protein 2 Proteins 0.000 description 8
- 241000700159 Rattus Species 0.000 description 8
- 210000001789 adipocyte Anatomy 0.000 description 8
- 235000019197 fats Nutrition 0.000 description 8
- 239000006228 supernatant Substances 0.000 description 7
- 235000013616 tea Nutrition 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 6
- 239000012141 concentrate Substances 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 5
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 5
- 235000005487 catechin Nutrition 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 4
- 108010023302 HDL Cholesterol Proteins 0.000 description 4
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 235000006468 Thea sinensis Nutrition 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 229950001002 cianidanol Drugs 0.000 description 4
- 239000006184 cosolvent Substances 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 238000003809 water extraction Methods 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 239000012675 alcoholic extract Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000021028 berry Nutrition 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 235000018823 dietary intake Nutrition 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 235000015203 fruit juice Nutrition 0.000 description 3
- 238000007602 hot air drying Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 235000009643 reducing diet Nutrition 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000030433 Epiphysiolysis of the hip Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 102000000019 Sterol Esterase Human genes 0.000 description 2
- 108010055297 Sterol Esterase Proteins 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002366 lipolytic effect Effects 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 235000020333 oolong tea Nutrition 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 230000004584 weight gain Effects 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- 102000000452 Acetyl-CoA carboxylase Human genes 0.000 description 1
- 108010016219 Acetyl-CoA carboxylase Proteins 0.000 description 1
- 206010003402 Arthropod sting Diseases 0.000 description 1
- 108010018763 Biotin carboxylase Proteins 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 229910000906 Bronze Inorganic materials 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- 241000209507 Camellia Species 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 238000012404 In vitro experiment Methods 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 238000000134 MTT assay Methods 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- LTYOQGRJFJAKNA-KKIMTKSISA-N Malonyl CoA Natural products S(C(=O)CC(=O)O)CCNC(=O)CCNC(=O)[C@@H](O)C(CO[P@](=O)(O[P@](=O)(OC[C@H]1[C@@H](OP(=O)(O)O)[C@@H](O)[C@@H](n2c3ncnc(N)c3nc2)O1)O)O)(C)C LTYOQGRJFJAKNA-KKIMTKSISA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002790 anti-mutagenic effect Effects 0.000 description 1
- 230000001028 anti-proliverative effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000010974 bronze Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 235000018597 common camellia Nutrition 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000009200 high fat diet Nutrition 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- LTYOQGRJFJAKNA-DVVLENMVSA-N malonyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 LTYOQGRJFJAKNA-DVVLENMVSA-N 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000003801 milling Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/332—Promoters of weight control and weight loss
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/214—Tea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/44—Supercritical state
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/37—Extraction at elevated pressure or temperature, e.g. pressurized solvent extraction [PSE], supercritical carbon dioxide extraction or subcritical water extraction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 녹차 열매 추출물의 제조방법 및 녹차 열매 추출물을 유효성분으로 함유하는 항비만용 조성물에 관한 것으로, 더 자세하게는 녹차 열매를 초임계 유체 추출하여 녹차 열매로부터 탈지하는 단계; 및 상기 탈지된 녹차 열매 초임계 추출물의 잔여물을 물 또는 알코올로 추출하는 단계를 포함하는 녹차 열매 추출물의 제조방법 및 상기의 방법으로 제조된 녹차 열매 추출물을 유효성분으로 함유하는 항비만용 조성물에 관한 것이다. 이에 따른, 녹차 열매 추출물을 유효성분으로 함유하는 항비만용 조성물은 체지방 축적을 억제하는 효과가 있다. The present invention relates to a method for preparing green tea fruit extract and an anti-obesity composition containing the green tea fruit extract as an active ingredient. More particularly, the present invention relates to a method for preparing a green tea fruit extract, And extracting the residue of the defatted green tea supercritical extract with water or alcohol, and a method for producing an antiobesity composition containing green tea fruit extract prepared by the above method as an active ingredient . Accordingly, the antiobesity composition containing the green tea extract as an active ingredient has an effect of inhibiting body fat accumulation.
Description
본 발명은 녹차 열매 추출물의 제조방법 및 녹차 열매 추출물을 유효성분으로 함유하는 항비만용 조성물에 관한 것으로, 더 자세하게는 녹차 열매를 초임계 유체 추출하여 녹차 열매로부터 탈지하는 단계; 및 상기 탈지된 녹차 열매 초임계 추출물의 잔여물을 물 또는 알코올로 추출하는 단계를 포함하는 녹차 열매 추출물의 제조방법 및 상기의 방법으로 제조된 녹차 열매 추출물을 유효성분으로 함유하는 항비만용 조성물에 관한 것이다.
The present invention relates to a method for preparing green tea fruit extract and an anti-obesity composition containing the green tea fruit extract as an active ingredient. More particularly, the present invention relates to a method for preparing a green tea fruit extract, And extracting the residue of the defatted green tea supercritical extract with water or alcohol, and a method for producing an antiobesity composition containing green tea fruit extract prepared by the above method as an active ingredient .
차는 오랜 세월 동안 인류가 가장 보편적으로 즐겨 왔으며 현대에도 많은 소비가 이루어지는 음료이다. 차는 Camellia sinenisi 라는 학명을 갖는 차나무의 잎을 발효시켜 만든다. 차의 종류는 발효공정의 차이에 의해 녹차, 우롱차, 홍차로 구분되며, 그 제조공정에 따라 차의 맛, 향, 색 그리고 성분에도 차이가 나게 된다. 녹차는 세계적으로 가장 많이 소비되고 있는 기호식품 중 가장 오래된 것 중의 하나이며, 예로부터 여러 가지 질병 치료제로도 사용되어 왔다. 녹차가 인체에 발휘하는 유리한 효과는 고전 및 현대 과학에 의하여 다양하게 규명되고 있다.
Tea is a drink that has been popular among humans for many years and consumes much in modern times. The tea is made by fermenting the leaves of a tea tree with the scientific name Camellia sinenisi. The types of tea are classified into green tea, oolong tea and black tea due to difference in fermentation process, and the taste, aroma, color and composition of tea are different according to the manufacturing process. Green tea is one of the oldest and most consumed foods in the world and has been used as a treatment for various diseases since ancient times. The beneficial effects of green tea on the human body have been variously characterized by classical and modern science.
즉, 녹차의 효능은 신종신경, 본초강목, 다경, 동의보감 등의 고정에서 살펴볼 수 있으며, 특히 다경에 나타난 녹차의 효능을 보면 녹차는 갈증을 없애고 음식을 소화시키며 담을 제거하고 잠을 쫓고 소변에 이로우며 눈을 밝게 하고 머리가 좋아지고 걱정을 씻어주며 비만을 막아준다고 되어 있다.
In other words, the efficacy of green tea can be seen in the fixation of the new nerve, the main bone gangmok, the multi gyeong, and the bronze gyeongbokgam. Especially, the green tea shows the effect of green tea, It is said to brighten the eyes, brighten the hair, wash away the worries, and prevent obesity.
또한, 녹차의 인체에 대한 효과로서 알려진 것으로는 다음과 같은 것들이 있다. 첫째, 각성 작용과 흥분 작용으로 대뇌 중추신경을 자극하여 정신을 맑게 하고 피로회복은 물론 기억력, 판단력, 지구력을 높여주며 정신적인 활력을 주어 기분을 상쾌하게 만들어 준다. 둘째, 항염과 세균발육 억제작용이 이질균, 장티푸스균, 포도상구균 등의 세균의 성장을 억제하고 식중독과 감기를 예방하며, 특히 식후의 음용은 입안 세균의 번식을 억제한다. 셋째, 고혈압과 동맥경화를 예방하는데 녹차의 카테킨류는 혈청의 콜레스테롤 함량을 크게 감소시키며 효율적으로 배설하게 하고 녹차잎 중의 비타민 C와 색소성분들도 고혈압과 동맥경화의 발병을 억제하는 것으로 보고되어 있다. 넷째, 녹차의 탄닌 중 폴리페놀 성분은 발암성을 갖는 불안정한 단자와 결합하여 암을 예방하고 암세포의 증식을 억제하는 효과를 나타낸다. 실제 영국의 암센터 스티치(Stich)시는 녹차, 홍차, 우롱차의 폴리페놀 성분이 발암물질에 대한 변이원성 억제 효과가 있음을 보고하였고, 일본의 하라세이히코 등은 녹차 추출액을 직접 암세포에 투여하여 고형종양의 증식 억제와 항돌연변이 효과를 입증하기도 했으며, 1993년 9월 1일 개최된 제2회 국제 녹차심포지엄 연구발표에서도 녹차가 암세포의 증식을 억제하며 에이즈 바이러스 억제는 물론 중금속 해독, 충치예방, 구취제거, 살균 효과가 있는 것으로 보고되었다.
In addition, there are the following known effects on the human body of green tea. First, by stimulating the cerebral central nervous system with arousal and excitement, it cleanses the mind and restores fatigue, as well as enhances memory, judgment, and endurance, and gives mental vitality to refresh the mood. Second, anti-inflammation and bacterial growth inhibition inhibits the growth of bacteria such as Diphtheria, Typhoid and Staphylococcus, prevents food poisoning and cold, and especially after eating, suppresses the growth of mouth bacteria. Third, catechins of green tea significantly reduce serum cholesterol content and efficiently excrete to prevent hypertension and arteriosclerosis, and vitamin C and pigment components in green tea leaves have also been reported to inhibit the development of hypertension and arteriosclerosis . Fourth, the polyphenol component in the tannins of green tea is combined with unstable terminals having carcinogenic properties to prevent cancer and inhibit the proliferation of cancer cells. In fact, the city of Stich in the UK reported that the polyphenol component of green tea, black tea, and oolong tea has an inhibitory effect on carcinogens, and Hashayihiko of Japan reported that green tea extract was directly administered to cancer cells It also proved the anti-proliferation and antimutagenic effects of solid tumors. In the 2nd International Green Tea Symposium, which was held on September 1st, 1993, green tea inhibited the proliferation of cancer cells and inhibited AIDS virus as well as heavy metal detoxification, It has been reported that it is effective to remove bad breath and to have sterilization effect.
차 잎은 다양한 형태로 널리 이용됨에도 불구하고 열매 및 열매에서 추출된 오일은 그 응용 제품이 다양하지 못하며 이용도가 매우 제한적이다. 최근 녹차 열매 추출물이 항균 및 항종양 등의 효능ㆍ효과가 있는 것으로 알려지면서 녹차 열매에 대한 관심이 커지고 있는 추세이다. "나 등(나효환, 백순옥, 한상빈, 복진영, 녹차 종자의 일반성분, 한국농화학회지, 35권, p272-275, 1992년)"의 연구결과에 의하면, 차나무 녹차 열매의 지방 분석을 보면 리놀산 및 리놀렌산과 같은 불포화 지방산과 토코페놀 등이 존재함으로써 다른 식물들의 종자와 큰 차이가 없으나, 특이하게도 사포닌의 함량이 매우 높게 함유된 것으로 보고된바 있다. 또한, Han L-K. 등(Han L-K., Kimura Y., Okuda H., Anti-Obesity effects of tea saponins., Prefectural University of Kumamoto, Japan)에 의하면 녹차 열매에 존재하는 사포닌 성분이 인체의 췌장에서 분비되는 지질분해효소(lipase)의 활성을 억제하여 지방의 소화 흡수를 저해함으로써 비만을 예방하는 효과가 있는 것으로 보고하고있다.
Although tea leaves are widely used in various forms, oils extracted from fruits and berries are not available in a variety of applications and are of limited use. Recently, it has become known that green tea fruit extract has efficacy and efficacy such as antibacterial and antitumor, and thus the interest in green tea is increasing. According to the results of the study of "Nah et al. (Na Hyo-hwan, Baek Soon-ok, Han Sang Bin, Bum Jin Young, General composition of green tea seeds, Journal of Korean Agricultural Science, Vol 35, p272-275, 1992) The presence of unsaturated fatty acids such as linolenic acid and tocopherol has not been found to be significantly different from the seeds of other plants, but it has been reported that the saponin content is very high. Also, Han LK. The saponin content of green tea extracts was significantly higher than that of the lipolytic enzymes secreted from the pancreas of the human body (Fig. lipase activity and inhibits digestion and absorption of fat, thereby preventing obesity.
최근에는 여러 가지 성분들의 약리적인 효과가 증명되면서 건강 음료로서의 가치가 새롭게 인식되어 널리 음용되고 있을 뿐만 아니라 녹차의 천연 향, 색, 맛을 이용한 기능성 식품, 화장품 등 다양한 분야에서 연구가 진행되고 있다. 그러나, 차나무 열매는 특별한 이용방안 없이 대부분 폐기 처분되고 있는 실정이며 이에 대한 연구 보고도 미흡한 실정이다. 차나무 종자는 천식이나 뇌명 등에 효과가 있어 민감요법으로 사용되기도 하고 수량이 많고 기름이 풍부하여 중국 등지에서는 일부 식용으로 이용되고 있다. 이와 같이 다양한 생리활성 등을 고려할 때 그 이용가치가 충분할 것으로 생각된다.
In recent years, the pharmacological effects of various ingredients have been proved, and the value as a health drink has been newly recognized and widely consumed, and research has been conducted in various fields such as functional foods using natural aroma, color, and taste of green tea, and cosmetics. However, the fruit of the tea is mostly disposed of without being used for special purposes. Tea seeds are effective for asthma, brain, etc. They are used as a sensitive therapy. They are high in yield and rich in oil, so they are used for some food in China. Considering such various physiological activities, the use value is considered to be sufficient.
이에, 본 발명자들은 녹차 열매 추출물을 함유한 항비만용 조성물을 연구하던 중, 녹차 열매를 초임계 추출하여 얻어진 탈지된 녹차 열매 추출물이 항비만 효과가 있음을 확인함으로써 본 발명을 완성하였다.
Accordingly, the inventors of the present invention completed the present invention by studying a composition for anti-obesity containing green tea extract, confirming that the defatted green tea extract obtained by supercritical extraction of green tea has an anti-obesity effect.
본 발명의 목적은 녹차 열매로부터 초임계 유체 추출방법을 통해 오일을 분리한 녹차 열매 추출물의 제조방법을 제공하는 것이다. It is an object of the present invention to provide a method for producing green tea fruit extract in which oil is separated from green tea fruit through a supercritical fluid extraction method.
본 발명의 다른 목적은 상기의 방법으로 제조된 녹차 열매 추출물을 유효성분으로 함유하는 항비만용 조성물을 제공하는 것이다.
Another object of the present invention is to provide a composition for anti-obesity containing green tea fruit extract prepared by the above method as an active ingredient.
상기의 과제를 해결하기 위하여, 본 발명은 녹차 열매를 일정 크기로 분쇄하는 단계(단계 1); 상기 녹차 열매 분쇄물을 보조용매와 함께 초임계 이산화탄소를 사용하여 초임계 추출하는 단계(단계 2); 및 상기 초임계 추출물을 물 또는 알코올로 추출하여 분리 정제하는 단계(단계 3)를 포함하는, 녹차 열매 추출물의 제조방법을 제공한다.
In order to solve the above-mentioned problems, the present invention provides a method for manufacturing a green tea product, comprising the steps of: (1) crushing green tea fruit to a predetermined size; Extracting the green tea powder with supercritical carbon dioxide together with an auxiliary solvent (step 2); And extracting and purifying the supercritical extract with water or alcohol (step 3).
상기 단계 1은, 녹차 열매의 탈지 추출 효율 증가를 위하여 녹차 열매를 열풍건조 한 후 일정크기로 분쇄하는 단계이다. The step 1 is a step of grinding the green tea fruit to a certain size after hot-air drying the green tea to increase the efficiency of degreasing extraction of the green tea fruit.
본 발명에서 사용하는 용어 '열풍건조'는 열풍건조기를 이용하여 일정온도에서 건조시키는 건조방식을 의미하여, 일반적으로 일정온도는 60℃의 온도를 의미한다. 상기 열풍건조는 수일 동안 수행할 수 있으며, 바람직하게는 1일 내지 5일 동안 수행할 수 있다. 더 바람직하게는 3일 동안 수행할 수 있다.
The term 'hot air drying' used in the present invention means a drying method in which drying is performed at a constant temperature using a hot air drier, and generally, a constant temperature means a temperature of 60 ° C. The hot air drying can be carried out for several days, preferably for 1 to 5 days. More preferably for 3 days.
상기 분쇄는 핀형분쇄기를 사용하여 녹차 열매를 0.5 mm 내지 2 mm 크기로 분쇄하는 것이 바람직하다. 만일, 상기 분쇄 시 입자 크기가 상기 범위 밖일 경우, 녹차 열매의 추출 효율이 떨어지는 단점이 있다. 특히, 0.5 mm 미만의 입자 크기에서는 초임계 추출 시 압력 부하로 인하여 추출 효율이 떨어지게 되고, 2 mm 보다 큰 입자 크기에서는 입자 속에 포함되어 있는 유효물질이 초임계 유체에 의해 외부로 추출되기 어려워 결과적으로 유효물질의 추출 효율이 떨어지는 단점이 있다.
The pulverization is preferably carried out by using a pin mill to pulverize the green tea fruit into a size of 0.5 mm to 2 mm. If the particle size during the above milling is outside the above range, there is a drawback that extraction efficiency of green tea fruit is deteriorated. Particularly, when the particle size is less than 0.5 mm, the extraction efficiency is lowered due to the pressure load during the supercritical extraction. When the particle size is larger than 2 mm, the effective substance contained in the particles is difficult to be extracted to the outside by the supercritical fluid. There is a disadvantage in that extraction efficiency of an effective substance is inferior.
상기 단계 2는, 녹차 열매의 오일을 추출하여 탈지하기 위한 단계로, 상기 단계 1을 거쳐 전처리된 녹차 열매를 일정 추출 조건하에서 초임계 추출하여 녹차 열매의 오일을 추출하는 단계이다. 상기 초임계 추출은 40℃ 내지 60℃ 온도 및 200 bar 내지 400 bar의 압력 하에서 수행하는 것이 바람직하다.
The step 2 is a step for extracting and degreasing the oil of the green tea, and extracting the green tea fruit by the supercritical extraction under the predetermined extraction condition through the step 1. The supercritical extraction is preferably carried out at a temperature of 40 ° C to 60 ° C and a pressure of 200 bar to 400 bar.
또한, 상기 단계 2의 초임계 추출은 초임계 이산화탄소를 사용하여 2 ㎖/min 내지 70 ㎖/min 유량으로 60분 내지 240분 동안 수행하는 것이 바람직하다.
The supercritical extraction in step 2 is preferably carried out at a flow rate of 2 ml / min to 70 ml / min using supercritical carbon dioxide for 60 minutes to 240 minutes.
상기 단계 3은, 상기 초임계 추출 후 얻어진 탈지된 녹차 열매 추출물의 잔여물로부터 항비만 유효성분을 추출하기 위하여 물 또는 알코올로 추출하는 단계이다. 상기 알코올은 메탄올 또는 에탄올인 것이 바람직하다. 또한, 상기 추출은 당업계에 알려져 있는 통상의 방법을 통하여 수행할 수 있다.
Step 3 is a step of extracting the anti-obesity active ingredient from the residue of the defatted green tea extract obtained after supercritical extraction with water or alcohol. The alcohol is preferably methanol or ethanol. In addition, the extraction can be carried out by a conventional method known in the art.
또한, 본 발명은 상기의 제조방법으로 제조된 녹차 열매 추출물을 유효성분으로 함유하는 항비만용 조성물을 제공한다.
The present invention also provides a composition for anti-obesity containing the green tea extract prepared by the above-described method as an active ingredient.
본 발명의 일 실시예에 따르면, 상기 녹차 열매 추출물을 유효성분으로 함유하는 항비만용 조성물은 in vivo 및 in vitro에서 비만 억제 효과가 있음을 확인하였다.
According to one embodiment of the present invention, an anti-obesity composition containing the green tea extract as an active ingredient is in vivo And in and it was confirmed that there was an effect of inhibiting obesity in vitro .
본 발명에 따른 제조방법은 녹차 열매로부터 항비만 효능이 있는 조성물을 추출할 수 있으며, 이를 이용하여 항비만용 제품 개발에 응용할 수 있다.
The production method according to the present invention can extract a composition having anti-obesity effect from green tea fruit, and can be applied to the development of an anti-obesity product using the composition.
도 1은, 본 발명의 일 실시예에 따른 (a) 녹차 열매 분쇄 전 시료 및 (b) 0.5 mm 입자 크기 녹차 열매 분쇄물의 외형을 나타낸 것이다. 또한, 0.5 mm 입자크기 녹차 열매 분쇄물의 200 bar에서의 (c) 40℃ 초임계 추출 후 시료, (d) 50℃ 초임계 추출 후 시료 및 (e) 60℃ 초임계 추출 후 시료의 외형을 나타낸 것이다. 또한, 0.5 mm 입자크키 녹차 열매 분쇄물의 300 bar에서의 (f) 40℃ 초임계 추출 후 시료, (g) 50℃ 초임계 추출 후 시료 및 (h) 60℃ 초임계 추출 후 시료의 외형을 나타낸 것이다. 또한, 0.5 mm 입자크기 녹차 열매 분쇄물의 400 bar에서의 (i) 40℃ 초임계 추출 후 시료, (j) 50℃ 초임계 추출 후 시료 및 (k) 60℃ 초임계 추출 후 녹차 열매 시료의 외형을 나타낸 것이다.
도 2는, 본 발명의 일 실시예에 따른 0.5 mm 입자 크기를 갖는 녹차 열매에서 초임계 유체 추출 후 얻은 오일 수율을 나타낸 그래프이다.
도 3은, 본 발명의 일 실시예에 따른 (a) 초임계 추출 후 탈지된 녹차 열매 및 (b) 열수 추출 후 외형을 나타낸 사진이다.
도 4는, 본 발명의 일 실시예에 따른 탈지되지 않는 열수 추출물 및 주정 추출물, 초임계 유체 추출 후 열수 추출물을 이용한 지방 세포 내에 TG의 생성에 미치는 녹차 열매 추출물의 효과를 나타낸 그래프이다.
도 5는, 본 발명의 일 실시예에 따른 탈지되지 않은 열수 추출물, 주정 추출물 및 초임계 유체 추출 후 열수 추출물을 이용한 primary culture된 지방세포에서 glycerol release에 미치는 녹차 열매 추출물의 효과를 나타낸 그래프이다.
도 6은, 본 발명의 일 실시예에 따른 탈지되지 않은 열수 추출물, 주정 추출물 및 초임계 유체 추출 후 열수 추출물을 이용한 지방세포에서 HSL(Hormone sentitive lipase), ATGL(Adipose triglyceride lipase), LPL(Lipoprotein lipase)에 미치는 녹차 열매 추출물의 효과를 나타낸 것이다.
도 7은, 본 발명의 일 실시예에 따른 탈지되지 않은 열수 추출물, 주정 추출물 및 초임계 유체 추출 후 열수 추출물을 이용한 FAS(Fatty acid synthase)의 유출량에 미치는 녹차 열매 추출물의 효과를 나타낸 것이다.
도 8은, 본 발명의 일 실시예에 따른 탈지되지 않은 열수 추출물, 주정 추출물 및 초임계 유체 추출 후 열수 추출물을 이용하여 제조한 식이 제품을 13주 동안 섭취 후 지방구를 H&E(Hematoxylin and Eosin) staining 실시하여 현미경으로 그 크기와 수를 관찰한 결과를 나타낸 것이다. Fig. 1 shows the appearance of (a) a green tea powder before grinding and (b) a 0.5 mm particle size green tea fruit powder according to an embodiment of the present invention. (C) sample after supercritical extraction at 40 ° C at 200 bar of 0.5 mm particle size green tea powder, (d) sample after supercritical extraction at 50 ° C, and (e) sample after supercritical extraction at 60 ° C. will be. (F) sample after supercritical extraction at 40 ° C, (g) sample after supercritical extraction at 50 ° C, and (h) sample after supercritical extraction at 60 ° C. will be. (I) the sample after supercritical extraction at 40 ° C, (j) the sample after supercritical extraction at 50 ° C, and (k) the appearance of the green tea extract after supercritical extraction at 60 ° C at 400 bar of 0.5 mm particle size green tea fruit pulverized product. Lt; / RTI >
FIG. 2 is a graph showing oil yields obtained after supercritical fluid extraction in a green tea fruit having a particle size of 0.5 mm according to an embodiment of the present invention. FIG.
FIG. 3 is a photograph showing (a) defatted green tea fruit after supercritical extraction and (b) hot water extraction according to an embodiment of the present invention.
FIG. 4 is a graph showing the effect of green tea fruit extract on the production of TG in adipocytes by using hot-water extract and non-degummed hot-water extract and hot-water extract after extracting supercritical fluid according to an embodiment of the present invention.
FIG. 5 is a graph showing the effect of green tea extract on glycerol release in primary cultured adipocytes using non-defatted hot-water extract, alcohol extract, and hot-water extract after supercritical fluid extraction according to an embodiment of the present invention.
FIG. 6 is a graph showing the effect of the HSL (hormone sentitive lipase), ATGL (Adipose triglyceride lipase), LPL (Lipoprotein lipase) of green tea fruit extract.
FIG. 7 shows the effect of green tea extract on the efflux of FAS (Fatty acid synthase) using unhatched hot-water extract, alcoholic extract, and hot-water extract after supercritical fluid extraction according to an embodiment of the present invention.
FIG. 8 is a graph showing the results of the H & E (Hematoxylin and Eosin) treatment of fat pad after 13 weeks of ingestion of the non-defatted hot water extract, the alcoholic extract and the hot water extract prepared after the supercritical fluid extraction, according to an embodiment of the present invention, staining and microscopic observation of the size and number.
이하, 하기의 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것은 아니다.
Hereinafter, the present invention will be described in more detail with reference to the following examples. These embodiments are only for describing the present invention more specifically, and the scope of the present invention is not limited by these examples.
실시예Example 1 내지 1 to 실시예Example 9: 분쇄된 녹차 열매의 9: Crushed green tea 초임계Supercritical 추출물 제조 Extract preparation
녹차 열매로부터 항비만 성분을 효율적으로 얻기 위하여 완전 탈지를 하였다. 탈지는 오일 성분을 효율적으로 추출할 수 있는 초임계 유체 추출 방법을 이용하여 수행하였다. 또한, 순수 이산화탄소 및 보조용매를 혼합하여 오일 추출 효율을 극대화하였다. 녹차 열매를 60℃에서 5일 동안 상온 건조한 후 핀형분쇄기를 이용하여 0.5 mm 내지 2 mm의 크기로 분쇄하여 전처리하였다. 초임계 추출 조건은 40℃, 50℃ 및 60℃ 온도로 조절하고, 각 온도 조건에서 압력을 200 bar, 300 bar 및 400 bar로 조절하여 각 추출조건에서 초임계 추출 장치(ISA-SCFE-0050-0100-080-re, 일신오토클레이브, 한국)을 이용하여 상기 전처리된 녹차 열매를 150 g의 양으로 주입하고 각 녹차 열매 시료당 90분 동안 초임계 추출을 실시하였다. 초임계 추출은 60 ㎖/min의 유량으로 90분 동안 초임계 이산화탄소를 사용하여 초임계 추출(SFE 추출법)하였다. 그 후, 초임계 이산화탄소를 흘리면서 녹차 열매 오일과 함께 분리조로 옮기고, 하부 밸브를 열어 초임계 추출 장치의 추출조 압력을 낮춰 초임계 유체 상태를 해제하여 추출물을 회수하였다. 하기 표 1에 초임계 추출 조건을 나타내었다. In order to obtain antioxidant component efficiently from green tea fruit, it was thoroughly degreased. Degreasing was performed by using a supercritical fluid extraction method which can efficiently extract oil components. In addition, pure carbon dioxide and co-solvent were mixed to maximize oil extraction efficiency. The green tea was dried at 60 ° C for 5 days at room temperature and then pulverized to a size of 0.5 mm to 2 mm using a pin mill. Supercritical extraction (ISA-SCFE-0050-B) was performed under the conditions of 40 ℃, 50 ℃ and 60 ℃ and the pressure was adjusted to 200 bar, 300 bar and 400 bar at each temperature condition. 0100-080-re, Ilshin Autoclave, Korea), and the supernatant was extracted for 90 minutes per each green tea sample. Supercritical extraction (SFE extraction) was carried out with supercritical carbon dioxide at a flow rate of 60 ml / min for 90 minutes. Subsequently, the supercritical carbon dioxide was transferred to the separation tank together with the green tea oil, and the lower valve was opened to lower the extraction tank pressure of the supercritical extraction apparatus, thereby releasing the supercritical fluid state and recovering the extract. The supercritical extraction conditions are shown in Table 1 below.
실시예Example 10: 녹차 열매 10: Green tea fruit 초임계Supercritical 추출 후 탈지된 녹차 열매의 After extraction of defatted green tea 열수Heat number 추출물 제조 Extract preparation
상기 실시예 1 내지 9를 통해 탈지된 녹차 열매 추출물 중 실시예 8의 시료를 사용하여 열수 추출을 실시하였다. 상기 실시예 8의 완전 탈지된 녹차 열매를 사용하여 초고속 진공 저온 추출기를 이용하여 열수 추출을 시행하였다. 3차 증류수를 이용하여 내부를 세척하고, 초임계 유체 추출 후 탈지된 녹차 열매 400 g을 농축 추출조에 3차 증류수 8 ℓ를 넣은 후 열을 가하여 50℃ 내지 60℃로 유지하면서 추출조를 55 rpm으로 회전시키면서 3시간 동안 추출하였다. 추출이 완료된 후에는 녹차 열매와 추출액을 분리, 진공농축 하였으며, 농축물은 동결건조하여 분말형태로 제조하였다.
The samples of Example 8 were subjected to hot water extraction through the degreased green tea extracts of Examples 1 to 9. Using the completely degreased green tea fruit of Example 8, hot water extraction was performed using an ultrahigh vacuum low temperature extractor. 400 g of the defatted green tea was added to the concentrated extraction tank with 8 L of distilled water and then heated to maintain the temperature of the extraction tank at 55 to 60 DEG C while maintaining the temperature at 50 to 60 DEG C, And extracted for 3 hours. After the extraction was completed, the green tea extract and the extract were separated and vacuum concentrated. The concentrate was lyophilized to a powder form.
비교예Comparative Example 1: 녹차 열매 1: Green tea berries 초임계Supercritical 추출 후 탈지된 녹차 열매의 주정 추출물 제조 Preparation of alcohol extract of defatted green tea after extraction
상기 실시예 8의 완전 탈지된 녹차 열매를 사용하여 회전 진공 농축 추출기를 이용하여 주정 추출을 수행하였다. 1차 증류수를 이용하여 내부를 세척하고, 초임계 유체 추출 후 탈지된 녹차 열매 400 g을 농축 추출조에 에탄올(주정) 8 ℓ를 넣은 후 열을 가하여 50℃ 내지 55℃로 유지하면서 추출조를 55 rpm으로 회전시키면서 3시간 동안 추출하였다. 추출이 완료된 후에는 녹차 열매와 추출액을 분리, 진공농축하였다. 농축물은 동결건조하여 분말형태로 제조하였다.
Using the completely degreased green tea fruit of Example 8, alcohol extraction was carried out using a rotary vacuum concentrator. 400 g of degreased green tea was added to 8 liters of concentrated ethanol after the extraction of supercritical fluid, followed by heating to maintain the temperature of the extraction tank at 55 ° C to 55 ° C. rpm and extracted for 3 hours. After the extraction was completed, the green tea extract and the extract were separated and concentrated in vacuo. The concentrate was lyophilized to give a powder.
비교예Comparative Example 2: 2: 초임계Supercritical 유체 추출 후 탈지된 녹차 열매 가루 제조 Manufacture of defatted green tea powder after fluid extraction
상기 실시예 8의 초임계 유체 추출하고 남은 완전 탈지된 녹차 열매를 1차 미분하여 직접 시료를 제조하였다. 이는 탈지된 녹차 열매 분말이 항비만 효과가 있는지를 비교하기 위해 준비하였다.
The supernatant fluid of Example 8 was extracted, and the remaining fully defatted green tea was firstly differentiated to prepare a direct sample. This was prepared to compare whether the defatted green tea powder had an anti-obesity effect.
비교예Comparative Example 3: 보조용매를 사용한 녹차 열매 3: Green tea using ancillary solvent 초임계Supercritical 추출물 제조 Extract preparation
녹차 열매로부터 순수 초임계 유체와 에탄올 보조용매를 혼합하여 추출한 추출물이 항비만 효과가 있는지 확인하기 위하여 보조용매를 사용하여 추출을 수행하였다. 녹차 열매를 60℃에서 5일 동안 열풍 건조한 후 핀형분쇄기를 이용하여 0.5 mm 내지 2 mm의 크기로 분쇄하여 전처리하였다. 초임계 추출 조건은 50℃ 온도와 400 bar 압력으로 조절하여 초임계 추출 장치(ISA-SCFE-0050-0100-080-re, 일신오토클레이브, 한국)을 이용하여 상기 전처리된 녹차 열매를 150 g의 양으로 주입하고 초임계 유체 추출을 수행하였다. 초임계 추출은 5단계로 실행하였다. 60 ㎖/min의 유량으로 90분 동안 순수 초임계 이산화탄소만을 사용하여 초임계 추출(SFE 추출법)하는 단계; 초임계 이산화탄소 60 ㎖/min 유량 및 보조용매 에탄올 2 ㎖/min 유량으로 60분 동안 추출하는 단계; 녹차 열매 추출물과 초임계 유체를 함계 흘려보내면서 추출물을 분리조로 옮기는 단계; 초임계 유체 추출물이 분리조로 넘어오면 하부 밸브를 열어 초임계 추출 장치의 추출조 압력을 낮춰 초임계 유체 상태를 해제하여 추출물을 회수하는 단계; 및 녹차 열매 추출물과 에탄올이 혼합된 혼합물질을 회전 진공 농축기로 농축하여 추출물질을 회수하는 단계로 수행하여, 녹차 열매 초임계 추출물을 제조하였다. 최종 추출양은 46.2 g이고, 추출 수율은 30.8%이었다.
Extraction was carried out using an auxiliary solvent in order to determine whether the extract obtained by mixing pure supercritical fluid and ethanol co - solvent from green tea fruit had an anti - obesity effect. The green tea fruits were dried in hot air at 60 ° C for 5 days and then pulverized to a size of 0.5 mm to 2 mm using a pin mill. The supercritical extraction conditions were adjusted to 50 ° C and a pressure of 400 bar. Using the supercritical extraction device (ISA-SCFE-0050-0100-080-re, Ilshin Autoclave, Korea), the pre- And supercritical fluid extraction was performed. The supercritical extraction was performed in five steps. Supercritical extraction (SFE extraction) using pure supercritical carbon dioxide at a flow rate of 60 ml / min for 90 minutes; Extracting the supercritical carbon dioxide at a flow rate of 60 ml / min and a co-solvent ethanol at a flow rate of 2 ml / min for 60 minutes; Transferring the green tea fruit extract and the supercritical fluid to the separation tank while flowing the mixture; When the supercritical fluid extract is passed to the separation tank, opening the lower valve to lower the extraction tank pressure of the supercritical extraction system to release the supercritical fluid state to recover the extract; And a mixture of green tea extract and ethanol was concentrated with a rotary vacuum concentrator to recover the extract material to prepare a supercritical green tea extract. The final extraction amount was 46.2 g, and the extraction yield was 30.8%.
비교예Comparative Example 4: 녹차 열매 4: Green tea berries 열수Heat number 추출물 제조 Extract preparation
녹차 열매에서 탈지하지 않고 직접 열수 추출한 물질의 항비만 효능을 확인하기 위하여 녹차 열매 열수 추출물을 제조하였다. 3차 증류수를 이용하여 내부를 세척하고, 미분쇄된 녹차 열매 원료 400 g을 농축 추출조에 3차 증류수 8 ℓ를 넣은 후 열을 가하여 50℃ 내지 60℃로 유지하면서 추출조를 55 rpm으로 회전시키면서 3시간 동안 추출하였다. 추출이 완료된 후에는 녹차 열매와 추출액을 분리, 진공농축 하였고 농축물은 동결건조하여 분말형태로 제조하였다.
In order to confirm the antiobesity effect of the hot - water - extracted material without the degreasing in the green tea, the hot - water extract of green tea was prepared. The inside of the green tea material was washed with tertiary distilled water, and 400 g of the raw material for the finely ground green tea was added to 8 liters of tertiary distilled water in the concentrate extracting tank. Heat was applied to the extracting tank while the extraction tank was rotated at 55 rpm And extracted for 3 hours. After the extraction was completed, the green tea extract and the extract were separated and vacuum concentrated. The concentrate was lyophilized to prepare powder form.
실험예Experimental Example 1: 온도 및 압력 추출 조건에 따른 추출 수율 분석 1: Analysis of extraction yield by temperature and pressure extraction conditions
상기 실시예 1 내지 9에서 얻어진 녹차 열매 초임계 유체 추출을 통해 얻은 오일량의 추출 수율을 조사하였다. 녹차 열매에서 초임계 유체 추출은 최종 열수 추출물에 오일 성분을 완전히 제거하기 위한 것으로, 추출물의 추출 수율을 하기 표 2 및 도 2에 나타내었다. The extraction yields of the oils obtained from the green tea supercritical fluid extraction obtained in Examples 1 to 9 were examined. Supercritical fluid extraction from green tea leaves is intended to completely remove the oil components from the final hot water extract. The extraction yield of the extract is shown in Table 2 and FIG. 2 below.
상기 표 2에 나타난 바와 같이, 실시예 8의 50℃, 400 bar 추출조건에서 얻어진 녹차 열매 초임계 추출물의 수율이 가장 놓은 것을 확인할 수 있었다.
As shown in Table 2, it was confirmed that the yield of supercritical green tea extract obtained at 50 ° C and 400 bar extraction condition of Example 8 was the highest.
실험예Experimental Example 2: 2: 초임계Supercritical 추출 후 탈지된 녹차 열매 Defatted green tea after extraction 열수Heat number 추출물의 Extract 조사포닌Crude saponin 함량 조사 Content survey
상기 실시예 10, 비교예 1, 비교예 2, 비교예 3 및 분쇄된 녹차 열매(원료)의 조사포닌 함량을 조사하기 위하여, 상기 각 시료에 각각 메탄올을 가하여 3회 반복 추출한 후 감압농축하였다. 이 농축물을 디에틸에테르로 30분간 가열하여 탈지시킨 후 다시 수포화 n-부탄올을 처리하여 n-부탄올층을 얻어 감압농축하였다. 각각의 잔류물은 항량을 측정한 후 하기의 식품공전의 공식에 따라 조사포닌의 양을 계산하였다. In order to examine the crude saponin content of the above Example 10, Comparative Example 1, Comparative Example 2, Comparative Example 3 and ground green tea (raw material), methanol was added to each of the above samples repeatedly extracted three times and then concentrated under reduced pressure. The concentrate was degreased by heating with diethyl ether for 30 minutes, and then treated with water-saturated n-butanol again to obtain an n-butanol layer, followed by concentration under reduced pressure. Each of the residues was measured for the amount of crude saponin according to the following formula after the constant amount was measured.
조사포닌 함량;Crude saponin content;
상기 식에서, A는 수포화 부탄올층을 농축건조한 후 플라스크의 무게(g), B는 항량으로 한 빈 플라스크의 무게(g), 및 S는 시료의 채취량(g)을 나타낸다. In the above equation, A represents the weight (g) of the flask after the water-saturated butanol layer is concentrated and dried, B represents the weight (g) of the empty flask with constant weight, and S represents the weight (g) of the sample.
상기 실시예 10, 비교예 1, 비교예 2, 비교예 3 및 분쇄된 녹차 열매(원료)의 조사포닌의 함량을 하기 표 3에 나타내었다. The content of crude saponin in Example 10, Comparative Example 1, Comparative Example 2, Comparative Example 3 and pulverized green tea (raw material) is shown in Table 3 below.
상기 표3에 나타난 바와 같이, 녹차 열매에는 42.52 ㎎/g 상당의 조사포닌을 함유하고 있다. 초임게 유체 추출을 통해 탈지한 후 열수 추출(실시예 10) 또는 탈지한 후 주정 추출(비교예 1)한 각 추출물을 동결건조하여 얻은 추출물의 조사포닌 함량은 각각 208.5 및 204.6으로 유사하였으며, 녹차 열매(원료) 자체보다 약 4.5배 이상의 조사포닌을 함유하고 있음을 확인할 수 있었다. 또한, 비교예 3에서 얻은 초임예 유체 및 보조용매를 함께 사용하여 초임게 추출한 추출물에서도 비교예 1의 초임계 추출 후 탈지된 녹차 열매 주정 추출물과 유사한 조사포닌량을 확인하였다.
As shown in Table 3, green tea fruit contains crude saponin equivalent to 42.52 mg / g. The crude saponin contents of the extracts obtained by freeze-drying the respective extracts obtained by defatting through fluid extraction, hot water extraction (Example 10) or degreasing and extracting the alcohol (Comparative Example 1) were 208.5 and 204.6, respectively, It was confirmed that crude saponin was contained about 4.5 times or more than the fruit (raw material) itself. In addition, the amount of crude saponin similar to that of the defatted green tea extract after the supercritical extraction of Comparative Example 1 was also confirmed in the extract obtained by using the supernatant fluid and the auxiliary solvent obtained in Comparative Example 3 together.
실험예Experimental Example 3: 3: 초임계Supercritical 추출 후 탈지된 녹차 열매 Defatted green tea after extraction 열수Heat number 추출물의 Extract inin vitrovitro 항비만Anti-obesity 효과 분석 Effect analysis
상기 비교예 4(녹차 열매 열수 추출물)과 실시예 10(초임계 추출 후 탈지된 녹차 열매 열수 추출물) 및 비교예 1(초임게 추출 후 탈지된 녹차 열매 주정 추출물)의 항비만 효과를 확인하기 위하여 성숙한 쥐의 지방세포를 배양하여 실험을 수행하였다. 40% high-fat diet로 비만이 유도된 16주령의 C57BL/6 mouse를 대상으로 지방조직을 추출하여 지방을 제거한 후 10% FBS를 포함한 DMEM에 primary culture하여 in vitro 항비만 실험을 수행하였다. 쥐의 지방세포에 독성을 일으키지 않는 농도를 확인하기 위하여 MTT assay 실험을 실시하였다. 세포에 안전한 추출물의 양은 세포를 키우기 위한 영양배지 1 ㎖ 당 비교예 4의 녹차 열매 열수 추출물 200 ㎍/㎖(이하, 열수 추출물 200), 비교예 1의 초임계 추출 후 탈지된 녹차 열매 주정 추출물 80 ㎍/㎖(이하, 주정 추출물 80) 및 실시예 10의 초임계 추출 후 탈지된 녹차 열매 열수 추출물 140 ㎍/㎖(이하, 초임계 추출물 140) 이다. 지방세포를 이용한 항비만 효과를 보기 위한 실험방법으로 지방세포에서 생성되는 TG(triglyceride)의 함량, glycerol 수치, hormone sensitive lipase(HSL), adipose triglyceride lipase(ATGL), lipoprotein lipase(LPL)의 수치를 측정하였다. In order to confirm the anti-obesity effect of Comparative Example 4 (green tea fruit extract), Example 10 (defatted green tea fruit extract after supercritical extraction) and Comparative Example 1 (defatted green tea extract) Experiments were performed by culturing adipocytes from adult rats. 40% high-fat diet for 16 weeks induced mast intended for C57BL / 6 mouse by extracting the fat tissue in DMEM containing 10% FBS after removing the fat in primary culture by In vitro anti - obesity experiments were performed. MTT assay was performed to determine the concentration of the adipocytes in rats. The amount of the cell extract-safe extract was determined by adding 200 μg / ml (hereinafter referred to as "hot water extract 200") of green tea fruit extract of Comparative Example 4 (hereinafter, referred to as "hot water extract 200") per 1 ml of nutrient medium for growing cells, Ug / ml (hereinafter, referred to as "alcohol extract") and 140 μg / ml of defatted green tea fruit extract after supercritical extraction of Example 10 (hereinafter, supercritical extract 140). The levels of triglyceride, glycerol, hormone sensitive lipase (HSL), adipose triglyceride lipase (ATGL) and lipoprotein lipase (LPL) in adipocytes were measured using an adipocyte- Respectively.
항비만 효과를 확인하기 위하여 지방 세포 내의 TG 함량 측정 결과를 도 4에 나타내었다. 도 4에 나타난 바와 같이, 통상 지방이 분해되면 TG 수치가 감소하게 되는데, 실험결과 녹차 열매 추출물 모두에서 TG 수치가 감소하였으며, 특히 비교예 1의 초임계 추출 후 탈지된 녹차 열매 주정 추출물과 실시예 10의 초임계 추출 후 탈지된 녹차 열매 열수 추출물에서 TG 수치가 크게 감소되었다. 이런 결과를 근거로하여 비교예 1의 초임계 추출 후 탈지된 녹차 열매 주정 추출물과 실시예 10의 초임계 추출 후 탈지된 녹차 열매 열수 추출물이 항비만 효과가 있는 것을 확인할 수 있다. The results of measuring the TG content in adipocytes are shown in Fig. 4 to confirm the anti-obesity effect. As shown in FIG. 4, when the fat was decomposed in general, the TG value decreased. Experimental results showed that the TG values decreased in all the green tea extract extracts. In particular, the defatted green tea extract and the extract After 10 supercritical extraction, the TG value was significantly decreased in the defatted green tea fruit juice extract. Based on these results, it can be confirmed that the defatted green tea juice extract after the supercritical extraction of Comparative Example 1 and the defatted green tea juice extract after the supercritical extraction of Example 10 have an anti-obesity effect.
녹차 열매 추출물의 지방세포 내 glycerol 수치 변화를 확인하기 위해 in vitro 실험을 실시하였으며, 그 결과를 도 5에 나타내었다. In vitro experiments were conducted to determine the changes in the glycerol levels in the adipocytes of the green tea extract. The results are shown in FIG.
도 5에 나타난 바와 같이, 통상적으로 지방이 분해되면 glycerol 수치가 증가하는데, 실험결과 주정 추출물 80과 초임계 추출물 140에서 glycerol 수치가 크게 증가하였다. 그러나 열수 추출물 200에서는 증가량이 적었다. 이 결과에서 주정 추출물과 탈지된 초임계 추출물이 항비만 효과가 있다는 것을 확인하였다. As shown in FIG. 5, when the fat is decomposed, the glycerol level increases. As a result, the glycerol level of the alcohol extract of supernatant 80 and supercritical extract 140 was greatly increased. However, the increase in hot water extract 200 was small. These results confirmed that the alcohol extract and defatted supercritical extract had an anti-obesity effect.
또한, 지방 세포 내에 HSL(hormone sensitive lipase), ATGL(Adipose Triglyceride lipase), LPL(Lipoprotein lipase)의 수치를 확인할 결과를 도 6에 나타내었다. 도 6에 나타난 바와 같이, 지방이 분해되면 HSL, ATGL 수치는 증가하고 LPL 수치는 감소하는데 실험결과 주정 추출물 80과 초임계 추출물 140에서 HSL, ATGL 수치가 크게 증가되었고 LPL 수치의 감소량이 크게 나타났다. 그러나 열수 추출물 200에서는 그 증감 폭이 작았다. 이런 결과에서 주정 추출물과 탈지된 초임계 추출물이 항비만 효과가 있음을 확인할 수 있었다.
The results of confirming the levels of HSL (hormone sensitive lipase), ATGL (Adipose Triglyceride lipase) and LPL (Lipoprotein lipase) in adipocytes are shown in FIG. As shown in FIG. 6, when fat was decomposed, HSL and ATGL levels increased and LPL levels decreased. Experimental results showed that the HSL and ATGL levels were significantly increased and the LPL levels were greatly decreased in the alcohol extract of supernatant 80 and the supercritical extract 140. However, the increase / decrease in hot water extract 200 was small. These results suggest that the alcohol extract and defatted supercritical extract have an anti - obesity effect.
또한, 녹차 열매 추출물의 FAS(Fatty acid synthase)에 미치는 효과를 알아보기 위하여 평가 실험을 실시하였으며, 그 결과를 도 7에 나타내었다. 지방산의 생합성은 아세릴 CoA 카르복시화 효소와 FAS(Fatty acid synthase)에 의해서 일어나는데 FAS는 아세틸 CoA와 말로닐 CoA에서 NAD(P)H를 조효소로 하여 지방산을 합성하는 효소이다. 따라서, FAS의 유출량을 확인함으로써 세포내 지방의 분해정도를 간접적으로 확인할 수 있다. In addition, an evaluation test was conducted to examine the effect of FAS (Fatty acid synthase) of green tea extract on the extract, and the results are shown in FIG. The biosynthesis of fatty acids is caused by the acetyl CoA carboxylase and FAS (Fatty acid synthase). FAS is an enzyme that synthesizes fatty acids by using NAD (P) H as the coenzyme in acetyl CoA and malonyl CoA. Therefore, the degree of degradation of intracellular fat can be indirectly confirmed by checking the amount of FAS released.
도 7에 나타난 바와 같이, 상기 열수 추출물 200, 주정 추출물 80 및 초임계 추출물 140을 처리한 결과, 초임계 추출물 140≥주정 추출물 80≥ 열수 추출물 200 순으로 FAS 유출 감소효과를 나타내었다. 초임계 추출물 140으로 처리한 군에서는 대조군에 비해 55%의 FAS가 감소한 것을 확인하였고, 주정 추출물 80으로 처리한 군에서는 대조군에 비해 45%, 열수 추출물 200으로 처리한 군에서는 21%의 FAS 유출 감소 효과가 나타났다. 주정 추출물 80과 초임계 추출물 140으로 처리한 군 간의 큰 차이는 없었으나, 열수 추출물 200을 포함한 이들 모두 지방분해 효과가 나타나는 것을 알 수 있었다.
As shown in FIG. 7, the hydrothermal extract 200, the alcohol extract 80 and the supercritical extract 140 were treated to show the FAS efflux reduction effect in the order of supercritical extract 140? Alcohol extract 80? Hot water extract 200. In the group treated with Supercritical Extract 140, 55% of the FAS was decreased compared to the control group. In the group treated with the extract of the alcoholic extract 80, 45% of the treated group and 21% of the treated group with FAS 200 Effect. There was no significant difference between the group treated with the alcohol extract of Supernatant 80 and Supercritical Extract 140, but all of them including the hydrothermal extract 200 showed the lipolytic effect.
위의 네 가지 실험 결과에서 녹차 열매로부터 얻은 초임계 추출 후 탈지된 녹차 열매 주정 추출물과 초임계 추출 후 탈지된 녹차 열매 열수 추출물은 항비만 효과가 있음을 확인하였다. 반면, 초임계 추출하지 않은 탈지되지 않은 녹차 열매 열수 추출물에서는 그 효과가 미미하였다.
In the above four experimental results, it was confirmed that the defatted green tea extract and the defatted green tea fruit juice extract after supercritical extraction from green tea extract had an anti - obesity effect. On the other hand, the effect was not significant in non - degreased green tea extracts without supercritical extraction.
실험예Experimental Example 4: 탈지된 녹차 열매 4: Defatted green tea fruit 열수Heat number 추출물의 Extract inin vivovivo 항비만Anti-obesity 효과 분석 Effect analysis
녹차 열매 추출물이 항비만 효과가 있음을 in vitro 실험에서 확인하였으며, 이를 동물 실험으로 추가 확인하였다. 시료는 상기 실시예 10 및 비교예 1, 비교예 2 및 비교예 3의 녹차 열매 초임계 추출 후 탈지된 녹차 열매 열수 추출물(실시예 10), 녹차 열매 초임계 추출 후 탈지된 녹차 열매 주정 추출물(비교예 1), 초임계 추출 후 탈지된 녹차 열매 분말(비교예 2) 및 이산화탄소 및 보조용매를 사용하여 초임계 추출한 추출물의 농축물(비교예 3)을 사용하여 항비만 실험을 진행하였다. Green tea extracts were found to have anti - obesity effect in vitro and further confirmed by animal experiments. The samples were prepared by dissolving the defatted green tea fruit hot water extract (Example 10) after supercritical green tea extract extraction of Example 10 and Comparative Example 1, Comparative Example 2 and Comparative Example 3 (Example 10), and defatted green tea extract (Comparative Example 1), a defatted green tea powder after supercritical extraction (Comparative Example 2), and a concentrate of supercritical extract extracted with carbon dioxide and a co-solvent (Comparative Example 3).
실험군은 총 12 그룹으로, wild type(이하, wild type)은 일반 쥐에 일반 식이를 섭취하게 하고, 그 외 11 그룹에는 비만 식이를 함께 섭취하게 하여 비만을 유도하여 실험군을 준비하였다. 항비만 실험을 위해 상기 시료는 쥐 몸무게 1 ㎏ 당 200 ㎎과 500 ㎎ 농도로 식이를 제조하여, 각각 200, 500 등으로 표기하여 실험을 실시하였다(이하, 열수 200, 열수 500, 주정 200, 주정 500, 초임계 탈지 200, 초임계 탈지 500, 초임계 농축 200 및 초임계 농축 500). 비만 유도 그룹 중, control 그룹(이하, control)은 일반 식이와 비만 식이를 혼합하여 섭취하도록 하였으며, 그 외 10 그룹은 일반 식이와 비만 식이를 혼합한 식이에 추가로 다이어트 식이(이하, positive control), 초임계 추출 하지 않은 탈지되지 않은 녹차 열매 열수 추출물(이하, 열수 500, 열수 200), 초임계 추출 후 탈지된 녹차 열매 주정 추출물 (이하, 주정 500, 주정 200), 초임계 추출 후 탈지된 녹차 열매 열수 추출물(이하, 초임계 탈지 500, 초임계 탈지 200), 초임계 추출한 녹차 오일(초임계 농축 500, 초임계 농축 200), 표준품으로 카테킨(이하, catechin)을 각각 혼합하여 식이를 제조하였다. Experimental groups were divided into 12 groups: wild type (wild type) and normal group (normal group). The other 11 groups were fed with obesity diet to induce obesity. For the anti-obesity test, the samples were prepared at a concentration of 200 ㎎ and 500 ㎎ per kg body weight of rats, respectively, and the experiments were carried out using 200, 500, and so on (hereinafter referred to as hot water 200, hot water 500, 500, supercritical degreasing 200, supercritical degreasing 500, supercritical enrichment 200 and supercritical enrichment 500). In the obesity induction group, the control group was fed a mixture of a normal diet and an obesity diet. In addition, the other 10 groups were fed a diet containing a normal diet and an obesity diet, , Defatted green tea extract (hereinafter referred to as "500", "200") after supercritical extraction, defatted green tea after supercritical extraction (Supercritical water extract (hereinafter, referred to as supercritical degreasing 500, supercritical degreasing 200), supercritical green tea oil (supercritical water concentration 500, supercritical water concentration 200), and catechin .
각 식이를 섭취한 쥐는 그룹당 8 마리로, 총 12 그룹으로 실험을 진행하였다. 실험쥐를 이용하여 각각의 식이를 섭취하기 전과 섭취한 후의 몸무게 변화를 측정하였으며, 또한 혈중 TG(triglyceride), 혈중 TC(total cholesterol), 혈중 HDL-C 혈중 glycerol 수치를 측정하였다. 또한, 간에서의 TG, TC 수치 측정, 지방구의 크게 및 수의 변화를 관찰하여 항비만 효과를 확인하였다. 실험군 12 그룹게 대해 식이를 섭취하기 전과 섭취한 후의 몸무게 변화를 측정하였으며, 그 결과를 하기 표 4에 나타내었다. Eight groups of rats fed each diet were divided into 12 groups. TG (triglyceride), TC (total cholesterol) and HDL-C blood glycerol levels were measured before and after ingestion of each diet using experimental rats. In addition, TG and TC levels were measured in the liver, and the changes in the number and size of lipids were observed to confirm the anti - obesity effect. The body weight change before and after the ingestion of 12 groups of the experimental group was measured, and the results are shown in Table 4 below.
상기 표 4에 나타난 바와 같이, 초임계 추출 후 탈지된 녹차 열매 주정 추출물(주정 500, 주정 200) 모두에서 체중 증가가 억제되었고, 초임계 추출 후 탈지된 녹차 열매 열수 추출물(초임계 탈지 200)에서 다이어트 식이를 먹인 것과 비슷한 체중 조절 효과가 있음을 확인하였다. As shown in Table 4, weight gain was suppressed in all of the defatted green tea extract (supernatant 500 and 200) after supercritical extraction, and the defatted green tea extract (supercritical defat 200) after supercritical extraction It was confirmed that weight control effect similar to that of diet was obtained.
항비만 효과를 확인하기 위하여, TG, TC, HDL-C, glycerol 수치를 확인하였의며, 그 결과를 하기 표 5에 나타내었다. TG, TC, HDL-C, and glycerol levels were confirmed to confirm the anti-obesity effect. The results are shown in Table 5 below.
상기 표 5에 나타난 바와 같이, 혈중 TG, TC 수치가 감소할수록, 또한 HDL-C와 glycerol 수치가 증가할수록 항비만 효과가 있는 것을 의미한다. 실험 결과 일반쥐에 비하여 녹차 열매 추출물을 섭취한 모든 그룹에서 항비만 효과가 있었으나, 초임계 추출 후 탈지된 녹차 열매 열수 추출물을 섭취한 쥐에서는 특히 뛰어난 항비만 효과가 있음을 확인하였다.
As shown in the above Table 5, as the blood TG and TC values decrease and the HDL-C and glycerol levels increase, it means that the anti-obesity effect is present. Experimental results showed that the antiobesity effect was found in all groups consuming the green tea extracts compared to the normal rats. However, it was confirmed that the rats fed with the defatted green tea fruit juice extract after supercritical extraction had excellent antiobesity effect.
또한, 간에서의 TG, TC 수치를 확인하였다. 통상적으로 간에서 TG와 TC 수치가 감소할수록 항비만 효과가 크다고 할 수 있는데, 주정 추출물 500과 초임계 탈지 200을 섭취한 쥐에게서 TG와 TC 수치가 control에 비교하여 감소하는 것을 확인하였으며, 이를 통해 상기 두 물질이 항비만 효과가 있음을 알 수 있었다. 하기 표 6에 그 결과를 나타내었다. In addition, TG and TC values in the liver were confirmed. In general, the lower the TG and TC values in the liver, the greater the anti-obesity effect. The TG and TC values in rats fed with the alcohol extract 500 and supercritical degreasing 200 were found to be decreased compared with the control. These two substances were found to have an anti-obesity effect. The results are shown in Table 6 below.
쥐에서 채취된 흰 지방의 지방구의 크기와 수를 H&E(Hematoxylin & Eosin) staining법을 통하여 염색한 세포를 현미경으로 관찰하였으며, 그 결과를 도 8에 나타내었다. Cells stained with H & E (Hematoxylin & Eosin) staining method were observed with a microscope. The results are shown in FIG. 8.
도 7에 나타난 바와 같이, 지방이 분해되면 지방구의 크기와 수가 감소하고 지방조직의 무게도 감소해야 항비만 효과가 있다고 할 수 있는데, 녹차 열매 추출물과 탈지된 초임계 추출물, 녹차 오일 식이를 섭취한 모든 그룹에서 지방구의 크기가 감소하는 것을 확인할 수 있었다. 특히, 열수 500, 주정 200, 초임계 탈지 500, 초임계 탈지 200, 초임계 농축 200에서 지방구의 크기가 작고, 지방조직의 수가 감소하여 항비만에 효과가 있음을 확인하였다.
As shown in FIG. 7, when the fat is decomposed, the size and number of the fat globes are decreased and the weight of the fat tissue is decreased. Thus, it can be said that the antiobesity effect is obtained. The green tea extract, the defatted supercritical extract, It was confirmed that the size of lipid sphere decreased in all groups. Especially, it was confirmed that the size of lipid sphere was small and the number of adipose tissue was decreased in the hydrothermal 500, ethanol 200, supercritical degreasing 500, supercritical degreasing 200, and supercritical enrichment 200.
상기의 in vitro 실험 및 in vivo 실험결과, 녹차 열매에서 주정 추출물 및 탈지된 초임계 열수 추출물이 항비만 효과가 큰 것을 확인할 수 있었다. 이는 녹차 열매 추출물이 항비만 효과가 있음을 알 수 있는 결과이다. As a result of the above in vitro and in vivo tests, it was confirmed that the ethanol extract and the defatted supercritical hot water extract in the green tea extract had a large anti-obesity effect. This result shows that green tea extract has anti - obesity effect.
Claims (6)
2) 상기 녹차 열매 분쇄물을 초임계 이산화탄소를 사용하여 초임계 추출하는 단계; 및
3) 상기 초임계 추출물의 잔여물을 물 또는 알코올로 추출하여 분리 정제하는 단계를 포함하는 방법으로 제조된 녹차 열매 추출물을 유효성분으로 함유하는 항비만용 조성물.
1) crushing the green tea to a predetermined size;
2) supercritical extraction of the green tea powder with supercritical carbon dioxide; And
3) extracting the residue of the supercritical extract with water or alcohol, and then separating and purifying the residue. The composition for an anti-obesity containing green tea extract as an active ingredient.
The antiobesity composition according to claim 1, wherein the pulverization is performed by pulverizing the green tea fruit to a size of 0.5 to 2 mm.
The antiobesity composition according to claim 1, wherein the supercritical extraction is carried out at a temperature of 40 ° C to 60 ° C and a pressure of 200 bar to 400 bar.
초임계 이산화탄소를 사용하여 2 ㎖/min 내지 70 ㎖/min 유량으로 60분 내지 240분 동안 초임계 추출하는 것을 특징으로 하는 녹차 열매 추출물을 유효성분으로 함유하는 항비만용 조성물.
The method of claim 1, wherein the supercritical extraction of step 2)
Characterized in that supercritical carbon dioxide is used for supercritical extraction at a flow rate of 2 ml / min to 70 ml / min for 60 to 240 min.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120069413A KR101414741B1 (en) | 2012-06-27 | 2012-06-27 | The manufacturing method of green tea nut extract and compositions for anti-obesity containing green tea nut extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020120069413A KR101414741B1 (en) | 2012-06-27 | 2012-06-27 | The manufacturing method of green tea nut extract and compositions for anti-obesity containing green tea nut extract |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20140001551A KR20140001551A (en) | 2014-01-07 |
KR101414741B1 true KR101414741B1 (en) | 2014-07-04 |
Family
ID=50139057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020120069413A KR101414741B1 (en) | 2012-06-27 | 2012-06-27 | The manufacturing method of green tea nut extract and compositions for anti-obesity containing green tea nut extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101414741B1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170050310A (en) * | 2015-10-30 | 2017-05-11 | 심영보 | Method for extraction of Paecilomyces sp. and the extracts |
KR20210056002A (en) | 2019-11-08 | 2021-05-18 | 주식회사네이처톡 | White green tea and its manufacturing method effective in the loss of body fat |
KR20220057928A (en) | 2020-10-30 | 2022-05-09 | (주)휴온스 | Composition for Preventing or Treating Obesity Comprising Enzyme-Treated Euphorbia humifusa Extract |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105341915A (en) * | 2015-11-11 | 2016-02-24 | 马超 | An anti-fatigue nutritional agent and a preparing method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005160348A (en) * | 2003-12-01 | 2005-06-23 | Kao Corp | Method for producing green tea extract |
KR20090010172A (en) * | 2006-03-23 | 2009-01-29 | 허발사이언스 싱가포르 피티이 리미티드 | Extracts and methods comprising green tea species |
-
2012
- 2012-06-27 KR KR1020120069413A patent/KR101414741B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005160348A (en) * | 2003-12-01 | 2005-06-23 | Kao Corp | Method for producing green tea extract |
KR20090010172A (en) * | 2006-03-23 | 2009-01-29 | 허발사이언스 싱가포르 피티이 리미티드 | Extracts and methods comprising green tea species |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20170050310A (en) * | 2015-10-30 | 2017-05-11 | 심영보 | Method for extraction of Paecilomyces sp. and the extracts |
KR101963640B1 (en) | 2015-10-30 | 2019-07-31 | 심영보 | Method for extraction of Paecilomyces sp. and the extracts |
KR20210056002A (en) | 2019-11-08 | 2021-05-18 | 주식회사네이처톡 | White green tea and its manufacturing method effective in the loss of body fat |
KR20220033479A (en) | 2019-11-08 | 2022-03-16 | 주식회사네이처톡 | White green tea and its manufacturing method effective in the loss of body fat |
KR20230047072A (en) | 2019-11-08 | 2023-04-06 | 주식회사네이처톡 | Manufacturing method of white green tea |
KR20220057928A (en) | 2020-10-30 | 2022-05-09 | (주)휴온스 | Composition for Preventing or Treating Obesity Comprising Enzyme-Treated Euphorbia humifusa Extract |
Also Published As
Publication number | Publication date |
---|---|
KR20140001551A (en) | 2014-01-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101414741B1 (en) | The manufacturing method of green tea nut extract and compositions for anti-obesity containing green tea nut extract | |
KR101914344B1 (en) | A moisturizing and anti-wrinkle cosmetic composition comprising fermented barley, fermented pear juice, fermented soybeans and fermented pomegranate extract and the method preparation of thereof | |
KR102298700B1 (en) | Facturing method of functional liquefied healthfoods using Gastroia elata Blume and Polygonum multiflorum Thunberg | |
CN105410569B (en) | A kind of preparation method to mulberry beverage of the alcoholic liver injury with protective effect | |
KR101830048B1 (en) | Food composition for improvement obesity or improvement hyperlipidemic with the extract of Terminalia chebula fruit and Phyllanthus emblica | |
KR101915071B1 (en) | Food Composition for Preventing and Improving Obesity Comprising Extracts from Fermented Coffee Robusta | |
KR20150121874A (en) | Neutraceutical composition comprising solid-state fermented coffee hot water extract manufactured by using Monascus ruber mycelium | |
CN111374309A (en) | Composition capable of regulating human immune system and preparation method thereof | |
KR20160139170A (en) | Manufacturing Method of Extracts Powder of Black Rice Bran And Extracts Powder of Black Rice Bran By The Same | |
KR20110066269A (en) | Method for manufacturing cheonggukjang containing red ginseng, and cheonggukjang produced thereby | |
Jia et al. | Hawk Tea, a traditional and healthy natural beverage in South China | |
KR101502798B1 (en) | Hepatic Fibrosis Cure Composition containing Methanol Extracts from Rhus Chinensis and Method for Producing the same | |
CN110354050A (en) | A kind of anti-aging composition, preparation method and applications | |
KR101771075B1 (en) | Composition for improving immune functions comprising extracts of fermented Arctium lappa L.and Spinacia oleracea | |
CN109430469A (en) | A kind of birch young pilose antler dark green tea and preparation method thereof with repairing pancreas function | |
KR102571313B1 (en) | Food composition for preventing or improving obesity comprising of extracts from Lizard's tail and Green tea | |
KR102691530B1 (en) | Method for increasing anti-obesity compounds of fruits of Cudrania tricuspidata and a composition for improving and preventing obesity comprising the increased anti-obesity compounds | |
WO2019090976A1 (en) | Jerusalem artichoke capsule and preparation method therefor | |
KR101509909B1 (en) | Sikhye comprising the extracts of achyranthes radix and manufacturing methods thereof | |
KR102365198B1 (en) | Facturing method of functional liquefied healthfoods using Gastroia elata Blume, Polygonum multiflorum Thunberg and mountain ginseng | |
KR102333879B1 (en) | A hyperlipemia improvement health functional food composition containing hot water extract of Ulmus macrocarpa Hance and Moringa as an active ingredient and its preparing method | |
KR102273428B1 (en) | An anti-obesity composition comprising a black ginger extract as a main component and a process for producing the same | |
KR20170064511A (en) | Anti-Obesity Food Composition Containing Solidago Virgaurea Extract and Method for Preparing the Same | |
KR20180088947A (en) | Manufacturing method of lotus leaf fermented extract, meat producing stuff having anti-obesity functional using the fermented extract anc meat product thereby | |
KR101781954B1 (en) | Method for producing mushroom mixed beverage using Lentinula edodes, Phellinus linteus and medical herb extract and mushroom mixed beverage produced by the same method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20170626 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20180508 Year of fee payment: 5 |